ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #6,008Hybrid

Current Research in Translational Medicine

Acronym:retram
•
Abbreviation (ISO):CURR RES TRANSL MED
•
Identifier (ISSN):2452-3186(Print)
•
Publisher:Elsevier Masson
Clarivate IF (2026)
3– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Research in Translational Medicine

WoS Q3
13461.920182.3520192.3820204.5120214.1920224.120233.220243202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q2
0.877
#6,008

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
72

72 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate6.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
23articles/year
22.52% Gold OA•85.71% Original Research

Aims & Scope

Current Research in Translational Medicine is a peer-reviewed journal, publishing worldwide clinical and basic research in the field of hematology, immunology, infectiology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases (2017 Impact Factor is 1.9). Core areas covered in Current Research in Translational Medicine are: Hematology, Immunology, Infectiology, Hematopoietic, Cell Transplantation, Cellular and Gene Therapy.

Topics Covered (Recognized by AI)
Medicine81.9%Biology78.1%Internal medicine70.4%Genetics67.4%Pathology54.4%Chemistry51.9%Immunology51.1%Biochemistry47.8%Cell biology31.9%Surgery31.5%Disease28.9%Gene24.1%Stem cell21.9%Endocrinology20.7%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank96/191
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank89/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year39
Total Citations4
2025
IF3
Articles / Year69
Total Citations155
2024
IF3.2
Articles / Year44
Total Citations128
2023
IF4.1
Articles / Year55
Total Citations268
2022
IF4.192
Articles / Year42
Total Citations383

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,008Scopus Q2SCImago Profile
Scopus Coverage:2016-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.877

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.74

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,221 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations327
3-Year Documents116
Citable Documents92

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2
HematologyQ2
Infectious DiseasesQ2
Medicine (miscellaneous)Q2
OncologyQ2
TransplantationQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Research in Translational Medicine (acronym: retram, abbr: CURR RES TRANSL MED, ISSN: 2452-3186) is a peer-reviewed international scholarly journal in the field of Biochemistry, published by Elsevier Masson in France. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.877 (Q2), an H-index of 72.

The journal enforces rigorous peer evaluation with an annual output of approximately 23 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,221 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Masson
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
65 RUE CAMILLE DESMOULINS, CS50083, ISSY-LES-MOULINEAUX, FRANCE, 92442

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7e95b9a3-ed7c-4e35-87f9-dcc05792fbbf
Database Updated: 2026-10-16